115 related articles for article (PubMed ID: 14768066)
1. Ximelagatran versus warfarin after total knee replacement.
Nishiguchi M; Takamura N; Aoyagi K
N Engl J Med; 2004 Feb; 350(6):616-7; author reply 616-7. PubMed ID: 14768066
[No Abstract] [Full Text] [Related]
2. Ximelagatran versus warfarin after total knee replacement.
Schillaci G; Pasqualini L; Mannarino E
N Engl J Med; 2004 Feb; 350(6):616-7; author reply 616-7. PubMed ID: 14768067
[No Abstract] [Full Text] [Related]
3. Ximelagatran versus warfarin after total knee replacement.
Banarer S
N Engl J Med; 2004 Feb; 350(6):616-7; author reply 616-7. PubMed ID: 14762192
[No Abstract] [Full Text] [Related]
4. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
Selçuk H; Selçuk MT; Maden O
Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079
[TBL] [Abstract][Full Text] [Related]
5. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
6. Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial.
Francis CW; Davidson BL; Berkowitz SD; Lotke PA; Ginsberg JS; Lieberman JR; Webster AK; Whipple JP; Peters GR; Colwell CW
Ann Intern Med; 2002 Oct; 137(8):648-55. PubMed ID: 12379064
[TBL] [Abstract][Full Text] [Related]
7. A review of the oral direct thrombin inhibitor ximelagatran: not yet the end of the warfarin era..
Mohapatra R; Tran M; Gore JM; Spencer FA
Am Heart J; 2005 Jul; 150(1):19-26. PubMed ID: 16084146
[TBL] [Abstract][Full Text] [Related]
8. Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty.
Lotke PA; Callaghan JJ; Dorr LD; Engh GH; Hanssen AD; Healy WL; Lachiewicz PF; Lonner JH; Nelson C; Ranawat CS; Ritter MA; Salvati EA; Sculco TP; Thornhill TS
J Bone Joint Surg Am; 2006 May; 88(5):1163; author reply 1163-5. PubMed ID: 16651602
[No Abstract] [Full Text] [Related]
9. Melagatran and ximelagatran: new drug. No real simplification of anticoagulant therapy.
Prescrire Int; 2005 Aug; 14(78):127-32. PubMed ID: 16106594
[TBL] [Abstract][Full Text] [Related]
10. Summaries for patients. Ximelagatran versus warfarin to prevent blood clots after knee replacement surgery.
Ann Intern Med; 2002 Oct; 137(8):I38. PubMed ID: 12379093
[No Abstract] [Full Text] [Related]
11. [Ximelagatran cannot be an alternative to standard warfarin therapy in chronic atrial fibrillation/ antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
Cavuşoğlu Y
Anadolu Kardiyol Derg; 2007 Jun; 7(2):217-8; author reply 218-9. PubMed ID: 17513231
[No Abstract] [Full Text] [Related]
12. Ximelagatran or warfarin in atrial fibrillation?
Eikelboom J; Hankey G
Lancet; 2004 Feb; 363(9410):734; author reply 734, 736. PubMed ID: 15001334
[No Abstract] [Full Text] [Related]
13. Ximelagatran or warfarin in atrial fibrillation?
MacAllister R; Hingorani AD; Casas JP
Lancet; 2004 Feb; 363(9410):735-6; author reply 736. PubMed ID: 15001337
[No Abstract] [Full Text] [Related]
14. Ximelagatran or warfarin in atrial fibrillation?
Stöllberger C; Finsterer J
Lancet; 2004 Feb; 363(9410):734-5; author reply 736. PubMed ID: 15001336
[No Abstract] [Full Text] [Related]
15. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding.
Douketis JD; Arneklev K; Goldhaber SZ; Spandorfer J; Halperin F; Horrow J
Arch Intern Med; 2006 Apr; 166(8):853-9. PubMed ID: 16636210
[TBL] [Abstract][Full Text] [Related]
16. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
Tandoğan I
Anadolu Kardiyol Derg; 2007 Jun; 7(2):216; author reply 218-9. PubMed ID: 17513230
[No Abstract] [Full Text] [Related]
17. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
Kiraç FS
Anadolu Kardiyol Derg; 2007 Jun; 7(2):214-5; author reply 218-9. PubMed ID: 17513229
[No Abstract] [Full Text] [Related]
18. Ximelagatran for secondary prevention of venous thromboembolism.
Böger C; Schroll S; Holmer S
N Engl J Med; 2004 Feb; 350(6):618-9; author reply 618-9. PubMed ID: 14768068
[No Abstract] [Full Text] [Related]
19. [New perspectives for anticoagulation in non-rheumatic atrial fibrillation: oral antithrombins].
Scardi S; Giansante C
Ital Heart J Suppl; 2004 Sep; 5(9):705-11. PubMed ID: 15568608
[TBL] [Abstract][Full Text] [Related]
20. Ximelagatran for secondary prevention of venous thromboembolism.
Vaknansky A; Kupfer Y; Tessler S
N Engl J Med; 2004 Feb; 350(6):618-9; author reply 618-9. PubMed ID: 14762193
[No Abstract] [Full Text] [Related]
[Next] [New Search]
